Tracon Pharmaceuticals Inc (TCON)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0322 -0.0113 (-25.98%) 12/02/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0322 unch (unch) -
for Mon, Dec 2nd, 2024
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -3,588 | -29,135 | -28,667 | -16,775 | -22,674 |
Depreciation Amortization | 7,359 | 505 | -39 | 29 | 45 |
Other Working Capital | -2,152 | -239 | 4,545 | -1,579 | -2,879 |
Other Operating Activity | 2,057 | 2,630 | 1,590 | 1,283 | 1,858 |
Operating Cash Flow | $3,676 | $-26,239 | $-22,571 | $-17,042 | $-23,650 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | N/A | 4,000 | -3,998 | 14,020 |
PPE Investments | N/A | -17 | -48 | -5 | N/A |
Investing Cash Flow | $N/A | $-17 | $3,952 | $-4,003 | $14,020 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 13,390 | N/A | 0 | N/A |
Debt Repayment | -20,500 | -1,680 | -2,800 | -1,400 | -1,400 |
Common Stock Issued | 7,961 | 7,974 | 13,360 | 38,164 | 2,306 |
Financing Cash Flow | $-12,539 | $19,684 | $10,560 | $36,764 | $906 |
Beginning Cash Position | 17,500 | 24,072 | 32,131 | 16,412 | 25,136 |
End Cash Position | 8,637 | 17,500 | 24,072 | 32,131 | 16,412 |
Net Cash Flow | $-8,863 | $-6,572 | $-8,059 | $15,719 | $-8,724 |
Free Cash Flow | |||||
Operating Cash Flow | 3,676 | -26,239 | -22,571 | -17,042 | -23,650 |
Capital Expenditure | N/A | -17 | -48 | -5 | 0 |
Free Cash Flow | 3,676 | -26,256 | -22,619 | -17,047 | -23,650 |